Delivery Order SPE2DB25D3012-SPE2DB25FWWTT
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,901.13, is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of April 3, 2025. There is no set-aside designation, indicating this was an open competition. As a large...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,240.82, is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $70,262.08, is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used to manage diabetes. The contract has a firm fixed-price pricing type and runs through January 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,859.88 firm fixed-price contract is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 8, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,790.24, is for the provision of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,945.19 firm-fixed-price contract is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used to manage diabetes. The contract has an ultimate completion date of November 6, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,958.48 firm fixed-price contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 9, 2023 and is not set aside for any specific business designation. AmerisourceBergen holds a substantial Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,824.15, is for the provision of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes medication. The contract has an ultimate completion date of January 7, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a $8,182.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. This contract is not associated with a set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,204.30, is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for the treatment of diabetes. The contract has a firm fixed price and an ultimate completion date of May 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that...